glp-1 macular degeneration Diabetic Retinopathy and Glucagon-Like Peptide-1 Agonists Anti-Inflammatory Effects of GLP-1R Activation

Adv Gerontol 2021;11:2617

49 OgawaK

Follow-up information in the available literature is heterogeneous and often limited

Injectable Weight Loss Different Weight Loss Injections Side Effects Of Weight Loss Injections Advantages of Weight Loss Injections Importance of Medical Consultation FAQs Weight loss injections have also become a top medical device among those looking for safe and reliable means of losing unwanted body fatparticularly when diet and exercise are not sufficient

Besides, GLP-1 RAs inhibit mitochondrial oxidative damage and attenuate reactive oxygen species production.47 Liraglutide has also been shown to suppress vascular cell adhesion molecule-1 expression in the endothelium.6 It also improves arterial stiffness and LV function, while reducing NT-proBNP levels, a biomarker for LV dysfunction.48 Vasodilatory and antioxidant actions could account for some of the antiatherogenic effects in GLP-1 RAs, therefore this drug class may be preferable in diabetic patients with predominant ASCVD risk.3 However, different results were found in studies of exenatide.15,20 Intravenous exenatide in patients after coronary artery bypass grafting surgery did not offer additional cardiovascular benefits compared to parenteral insulin.20 Differences have been suggested to be related to different immunogenicity profiles and signalling pathways in exendin-4 and GLP-1 based agonists.46 Exendin-4 based agonists are postulated to be more immunogenic and cause injection site reactions, leading to higher drug discontinuation rate and diminished benefits in the EXSCEL trial.15,46 Given the conflicting evidence, CVOTs were conducted to study GLP-1 RAs with different populations and formulations